Companies
Creative Proteomics
runs an integrated multi-omics CRO offering deep central-carbon-metabolism and lipidomics panels using triple-quadrupole and Orbitrap mass spectrometry alongside capillary-electrophoresis-MS, serving both academic and industrial clients.
- Country
- United States
multi-omics
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | No public information available regarding funding rounds medium confidence | askcyborg.com |
| Headcount | Estimates range from 2 to 100 employees medium confidence | askcyborg.com |
| Revenue | Estimated annual revenue is approximately $4.5 million USD medium confidence | askcyborg.com |
| Certification | No quality certifications publicly available medium confidence | thomasnet.com |
| Regulatory approval | Provides services for regulatory support, such as mutagenicity testing, but no specific regulatory approvals are documented medium confidence | askcyborg.com |
Independent sources: askcyborg.com · thomasnet.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Metabolomics (service) | bioinformatics-omics | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.